Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia (2024)
- Authors:
- Lima, Keli
- Nogueira, Frederico Lisboa
- Cipelli, Marcella
- Carvalho, Maria Fernanda Lopes
- Martins, Diego Antonio Pereira
- Silva, Wellington Fernandes da
- Medeiros, Rita de Cássia Cavaglieri
- Nardinelli, Luciana
- Leal, Aline de Medeiros
- Velloso, Elvira Deolinda Rodrigues Pereira
- Bendit, Israel
- Camara, Niels Olsen Saraiva
- Schuringa, Jan Jacob
- Machado Neto, João Agostinho
- Rego, Eduardo Magalhães
- Lima, Keli
- USP affiliated authors: VELLOSO, ELVIRA DEOLINDA RODRIGUES PEREIRA - FM ; BENDIT, ISRAEL - FM ; CÂMARA, NIELS OLSEN SARAIVA - ICB ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; REGO, EDUARDO MAGALHÃES - FM ; LIMA, KELI CRISTINA DE - FM ; NOGUEIRA, FREDERICO LISBOA - FM ; CIPELLI, MARCELLA - ICB ; CARVALHO, MARIA FERNANDA LOPES - ICB ; NARDINELLI, LUCIANA - FM
- Unidades: FM; ICB
- DOI: 10.1016/j.ejphar.2024.176723
- Subjects: FARMACOLOGIA; IMUNOLOGIA; ANTINEOPLÁSICOS; SOBREVIVÊNCIA CELULAR; INIBIDORES DE ENZIMAS; PROTEÍNAS QUINASES; PROTEÍNAS PROTO-ONCOGÊNICAS; NEOPLASIAS POR TIPO HISTOLÓGICO; LEUCEMIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Pharmacology
- ISSN: 1879-0712
- Volume/Número/Paginação/Ano: v. 977, art. 176723, 11 p., 2024
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
LIMA, Keli et al. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia. European Journal of Pharmacology, v. 977, p. 11 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2024.176723. Acesso em: 27 dez. 2025. -
APA
Lima, K., Nogueira, F. L., Cipelli, M., Carvalho, M. F. L., Martins, D. A. P., Silva, W. F. da, et al. (2024). Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia. European Journal of Pharmacology, 977, 11 . doi:10.1016/j.ejphar.2024.176723 -
NLM
Lima K, Nogueira FL, Cipelli M, Carvalho MFL, Martins DAP, Silva WF da, Medeiros R de CC, Nardinelli L, Leal A de M, Velloso EDRP, Bendit I, Camara NOS, Schuringa JJ, Machado Neto JA, Rego EM. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia [Internet]. European Journal of Pharmacology. 2024 ; 977 11 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.ejphar.2024.176723 -
Vancouver
Lima K, Nogueira FL, Cipelli M, Carvalho MFL, Martins DAP, Silva WF da, Medeiros R de CC, Nardinelli L, Leal A de M, Velloso EDRP, Bendit I, Camara NOS, Schuringa JJ, Machado Neto JA, Rego EM. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia [Internet]. European Journal of Pharmacology. 2024 ; 977 11 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.ejphar.2024.176723 - Clinical significance of Philadelphia-like-related genes in a resource-constrained setting of adult B-acute lymphoblastic leukemia patients
- Impact of Ph-like gene signatures on clinical outcomes in adult B-all patients in Resource-Constrained settings
- Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia
- Metabolic reprogramming represents a targetable mechanism to overcome acquired resistance to venetoclax in acute myeloid leukemia
- Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents
- Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells
- Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia
- Gut microbiota resilience mechanisms against pthogen infection and its role in infammatory Bowel Disease
- Synthesis and evaluation of 2-substituted quinazolin-4(3H)-ones as potential antileukemic agents
- All-trans retinoic acid potentiates cell death induced by quizartinib in acute myeloid leukemia with FLT3-ITD mutations
Informações sobre o DOI: 10.1016/j.ejphar.2024.176723 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
